VONLEROLIZUMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 11:24:56 GMT 2023` Edited by `admin` on `Sat Dec 16 11:24:56 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	C78148TF1D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VONLEROLIZUMAB

Official Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF4(TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, ACT35, OX40, CD134)), HUMANIZED MONOCLONAL ANTIBODY

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4 (ACT35 ANTIGEN, OX40L RECEPTOR, CD134 ANTIGEN))HUMANIZED MOUSE MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED MOUSE VH (HOMO SAPIENS IGHV1-46*01 (81%)

Systematic Name

English

RG 7888 [WHO-DD]

Common Name

English

R0-7021608

Code

English

Vonlerolizumab [WHO-DD]

Common Name

English

RG7888

Code

English

POGALIZUMAB

Official Name

English

vonlerolizumab [INN]

Common Name

English

MOXR-0916

Code

English

R07021608

Code

English

RG-7888

Code

English

MOXR0916

Code

English

VONLEROLIZUMAB [USAN]

Common Name

English

Code System Code Type Description

CAS

1638935-72-4